Looks a little sensitive to me but hey a FDA meeting is a FDA meeting!
"Executive Chairman Dr Graham Melrose said, “Given the urgent medical need for new antibiotics, in the face of rising incidence of drug resistant superbugs, we look forward to meeting with the FDA to explore the most efficient regulatory pathway for RECCE® 327”."
Should be held NOW!
IMO!
Ann: Meeting with US FDA on Phase I Clinical Trial for RECCE 327, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
36.0¢ |
Change
0.025(7.46%) |
Mkt cap ! $104.1M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 36.0¢ | 34.0¢ | $87.14K | 248.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 23061 | 34.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.0¢ | 20951 | 3 |
View Market Depth
| Last trade - 16.10pm 22/07/2025 (20 minute delay) ? |
| RCE (ASX) Chart |